Back
Results - Announcements
Viyash Scientific Ltd consolidated sales up 2.87% on year in Q2FY2026, net profit expanded by 19.45%
11-Aug-2026, 03:49
Viyash Scientific Ltd share price softened by 1.19% to Rs 273.8. The Company's net profit rose by 19.45% to Rs 79.29 crore, while revenue from operations slightly gained 2.87% to Rs 946.36 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, gaining 4.63%. It has improved by 0.56% over last one week and heading higher by 13.27% in last one month while the market capitalization of Viyash Scientific Ltd has inched up 2.76% and 21.93% in the same period respectively. Profit before tax (PBT) of Viyash Scientific Ltd stood at Rs 112.41 crore in Q2 FY26, expanding by 132.54% year-on-year, and dropping 10.24% quarter-on-quarter. EBITDA came in at Rs 170 crore, rallying 51.94% YoY and easing 1.03% sequentially. Total expenses posted a minor rise of 4.22% to Rs 829.75 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 402.34 crore, going up by 10.56% YoY, while employee benefits expense was at Rs 162.65 crore, rising by 8.56% YoY. For the TTM ended FY26, revenue from operations grew 13.75% to Rs 3420.31 crore, while net profit surged by 1324.54% to Rs 224.65 crore, compared to previous TTM. EBITDA jumped by 34797% to Rs 608.98 crore, and PBT jumped 2548.10% to Rs 349.02 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 322.91 crore in FY26, as against Rs 344.8 crore in FY25. Viyash Scientific Ltd soared by 54.86% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
Viyash Scientific Ltd share price softened by 1.19% to Rs 273.8. The Company's net profit rose by 19.45% to Rs 79.29 crore, while revenue from operations slightly gained 2.87% to Rs 946.36 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, gaining 4.63%. It has improved by 0.56% over last one week and heading higher by 13.27% in last one month while the market capitalization of Viyash Scientific Ltd has inched up 2.76% and 21.93% in the same period respectively. Profit before tax (PBT) of Viyash Scientific Ltd stood at Rs 112.41 crore in Q2 FY26, expanding by 132.54% year-on-year, and dropping 10.24% quarter-on-quarter. EBITDA came in at Rs 170 crore, rallying 51.94% YoY and easing 1.03% sequentially. Total expenses posted a minor rise of 4.22% to Rs 829.75 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 402.34 crore, going up by 10.56% YoY, while employee benefits expense was at Rs 162.65 crore, rising by 8.56% YoY. For the TTM ended FY26, revenue from operations grew 13.75% to Rs 3420.31 crore, while net profit surged by 1324.54% to Rs 224.65 crore, compared to previous TTM. EBITDA jumped by 34797% to Rs 608.98 crore, and PBT jumped 2548.10% to Rs 349.02 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 322.91 crore in FY26, as against Rs 344.8 crore in FY25. Viyash Scientific Ltd soared by 54.86% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
